Drug intelligence / Profile preview

AlloRx (Foundation for Orthopaedics and Regenerative Medicine)

Development stage: Unknown
Lead developer: Vitro Biopharma
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intrathecal

Overview

AlloRx is an allogeneic cell therapy composed of cultured mesenchymal stem cells (MSCs) derived from human umbilical cord tissue. Developed by The Foundation for Orthopaedics and Regenerative Medicine, it is currently being evaluated for the treatment of amyotrophic lateral sclerosis (ALS). The therapy is administered via intrathecal injection, where the MSCs are intended to provide neuroprotective and immunomodulatory effects to slow the progression of the disease. AlloRx also serves as the source for AlloEx, an exosome-rich secretome containing various micro-RNAs and cytokines.

Brand names: AlloRx
Other names: allogeneic umbilical cord-derived mesenchymal stem cellscultured allogeneic adult umbilical cord derived mesenchymal stem cells

Beyond the preview

Go deeper on AlloRx (Foundation for Orthopaedics and Regenerative Medicine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlloRx (Foundation for Orthopaedics and Regenerative Medicine).

Explore the full profile